New Search

Export article
Open Access

SARS-CoV-2 and Autoimmune Cytopenia

Published: 20 July 2021
 by  MDPI
 in Hemato
Hemato , Volume 2, pp 463-476; doi:10.3390/hemato2030029

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a variety of clinical manifestations related to viral tissue damage, as well as a virally induced immune response. Hyperstimulation of the immune system can serve as a trigger for autoimmunity. Several immune-mediated manifestations have been described in the course of SARS-CoV-2 infection. Immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) are the most common hematologic autoimmune disorders seen in the course of SARS-CoV-2 infection. Vaccine-induced thrombocytopenia is a unique autoimmune hematologic cytopenia associated with SARS-CoV-2 vaccination. This paper will review the current literature on the association of SARS-CoV-2 infection and vaccination with autoimmune cytopenias and the clinical course of autoimmune cytopenias in patients with COVID-19.
Keywords: autoimmune / cytopenia / autoimmune hemolytic anemia / cold agglutinin syndrome / COVID-19 / SARS-CoV-2 / ITP / immune thrombocytopenia

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Hemato" .
References (94)
    Back to Top Top